118 related articles for article (PubMed ID: 25186116)
21. Cost-Effectiveness Analysis of Digital Breast Tomosynthesis Added to Synthetic Mammography in Breast Cancer Screening in Brazil.
Couto HL; Gargano LP; de Oliveira VM; Coelho BA; Pessoa EC; Hassan AT; Silva AL; Urban LABD; Fernandes LC; Sharma N; Mann R; McIntosh SA; Zanghelini F
Pharmacoecon Open; 2024 May; 8(3):403-416. PubMed ID: 38233699
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk.
Ahern CH; Shih YC; Dong W; Parmigiani G; Shen Y
Br J Cancer; 2014 Oct; 111(8):1542-51. PubMed ID: 25137022
[TBL] [Abstract][Full Text] [Related]
23. An Exploratory Analysis of the Cost-Effectiveness of a Multi-cancer Early Detection Blood Test Compared with Standard of Care Screening in Ontario, Canada.
Lewis D; Wong WWL; Lipscomb J; Horton S
Pharmacoeconomics; 2024 Apr; 42(4):393-407. PubMed ID: 38150120
[TBL] [Abstract][Full Text] [Related]
24. Cost-Utility Analysis of Early Detection with Ultrasonography of Differentiated Thyroid Cancer: A Retrospective Study on a Korean Population.
Baek HS; Ha J; Kim K; Bae JS; Kim JS; Kim S; Lim DJ; Kim CM
Endocrinol Metab (Seoul); 2024 Apr; 39(2):310-323. PubMed ID: 38590123
[TBL] [Abstract][Full Text] [Related]
25. Using Risk Stratification to Optimize Mammography Screening in Chinese Women.
Leung K; Wu JT; Wong IO; Shu XO; Zheng W; Wen W; Khoo US; Ngan R; Kwong A; Leung GM
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377936
[TBL] [Abstract][Full Text] [Related]
26. Systematic reviews as a "lens of evidence": Determinants of cost-effectiveness of breast cancer screening.
Mandrik O; Ekwunife OI; Meheus F; Severens JLH; Lhachimi S; Uyl-de Groot CA; Murillo R
Cancer Med; 2019 Dec; 8(18):7846-7858. PubMed ID: 31568702
[TBL] [Abstract][Full Text] [Related]
27. Breast Cancer Risk and Screening Mammography Frequency Among Multiethnic Women.
Zhang J; McGuinness JE; He X; Jones T; Silverman T; Guzman A; May BL; Kukafka R; Crew KD
Am J Prev Med; 2023 Jan; 64(1):51-60. PubMed ID: 36137818
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme.
Posso M; Carles M; Rué M; Puig T; Bonfill X
PLoS One; 2016; 11(7):e0159806. PubMed ID: 27459663
[TBL] [Abstract][Full Text] [Related]
29. Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women.
Haghighat S; Akbari ME; Yavari P; Javanbakht M; Ghaffari S
Iran J Cancer Prev; 2016 Feb; 9(1):e5443. PubMed ID: 27366315
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of targeted versus tailored interventions to promote mammography screening among women military veterans in the United States.
Lairson DR; Chan W; Chang YC; del Junco DJ; Vernon SW
Eval Program Plann; 2011 May; 34(2):97-104. PubMed ID: 20810168
[TBL] [Abstract][Full Text] [Related]
31. Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status.
Mandelblatt JS; Schechter CB; Yabroff KR; Lawrence W; Dignam J; Extermann M; Fox S; Orosz G; Silliman R; Cullen J; Balducci L;
J Gen Intern Med; 2005 Jun; 20(6):487-96. PubMed ID: 15987322
[TBL] [Abstract][Full Text] [Related]
32. Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population.
Kerlikowske K; Chen S; Golmakani MK; Sprague BL; Tice JA; Tosteson ANA; Rauscher GH; Henderson LM; Buist DSM; Lee JM; Gard CC; Miglioretti DL
J Natl Cancer Inst; 2022 May; 114(5):676-685. PubMed ID: 35026019
[TBL] [Abstract][Full Text] [Related]
33. Flexible transition probability model for assessing cost-effectiveness of breast cancer screening extension to include women aged 45-49 and 70-74.
Shafik N; Ilmonen P; Viitasaari L; Sarkeala T; Heinävaara S
PLoS One; 2023; 18(6):e0287486. PubMed ID: 37352191
[TBL] [Abstract][Full Text] [Related]
34. Health utility values of breast cancer treatments and the impact of varying quality of life assumptions on cost-effectiveness.
Kregting LM; Vrancken Peeters NJMC; Clarijs ME; Koppert LB; Korfage IJ; van Ravesteyn NT
Int J Cancer; 2024 Jul; 155(1):117-127. PubMed ID: 38478916
[TBL] [Abstract][Full Text] [Related]
35. Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study.
de Ligt KM; Witteveen A; Siesling S; Steuten LMG
BMC Cancer; 2018 Jan; 18(1):96. PubMed ID: 29361911
[TBL] [Abstract][Full Text] [Related]
36. False-positive screening mammograms and biopsies among women participating in a Canadian provincial breast screening program.
Coldman AJ; Phillips N
Can J Public Health; 2012 Nov; 103(6):e420-4. PubMed ID: 23618020
[TBL] [Abstract][Full Text] [Related]
37. Is Age-targeted full-field digital mammography screening cost-effective in emerging countries? A micro simulation model.
Souza FH; Polanczyk CA
Springerplus; 2013; 2():366. PubMed ID: 23961428
[TBL] [Abstract][Full Text] [Related]
38. Personalized breast cancer screening strategies: A systematic review and quality assessment.
Román M; Sala M; Domingo L; Posso M; Louro J; Castells X
PLoS One; 2019; 14(12):e0226352. PubMed ID: 31841563
[TBL] [Abstract][Full Text] [Related]
39. Harms and benefits of mammographic screening for breast cancer in Brazil.
Migowski A; Nadanovsky P; Manso de Mello Vianna C
PLoS One; 2024; 19(1):e0297048. PubMed ID: 38271392
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of non-invasive assessment in the Dutch breast cancer screening program versus usual care: a randomized controlled trial.
Timmers JM; Damen JA; Pijnappel RM; Verbeek AL; den Heeten GJ; Adang EM; Broeders MJ
Can J Public Health; 2014 Jul; 105(5):e342-7. PubMed ID: 25365268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
